SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-003384
Filing Date
2014-05-15
Accepted
2014-05-15 16:11:27
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0314_immudyne.htm 10-Q 417953
2 CERTIFICATION f10q0314ex31i_immudyne.htm EX-31.1 14984
3 CERTIFICATION f10q0314ex32i_immudyne.htm EX-32.1 5255
  Complete submission text file 0001213900-14-003384.txt   2645807

Data Files

Seq Description Document Type Size
4 XBRL immd-20140331.xml EX-101.INS 279984
5 XBRL immd-20140331.xsd EX-101.SCH 33117
6 XBRL immd-20140331_cal.xml EX-101.CAL 26111
7 XBRL immd-20140331_def.xml EX-101.DEF 76616
8 XBRL immd-20140331_lab.xml EX-101.LAB 246582
9 XBRL immd-20140331_pre.xml EX-101.PRE 161659
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184487 | Film No.: 14847314
SIC: 2833 Medicinal Chemicals & Botanical Products